Symptoms Experience and Quality of Life in The Patients With Breast Cancer Receiving The Taxane Class of Drugs
The aim of this study is to evaluate the symptoms experience and quality of life in patients with breast cancer receiving the taxane class of drugs. This study was performed between November 2015 March 2016 in a chemotherapy unit of a university hospital with 48 patients, who agreed to participate i...
Saved in:
Published in | European journal of breast health Vol. 14; no. 3; pp. 148 - 155 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Turkey
Turkish Federation of Breast Diseases Associations
01.07.2018
Galenos Publishing House |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The aim of this study is to evaluate the symptoms experience and quality of life in patients with breast cancer receiving the taxane class of drugs.
This study was performed between November 2015 March 2016 in a chemotherapy unit of a university hospital with 48 patients, who agreed to participate in the study. The Memorial Symptom Rating Score (MSAS), Socio-demographic and Clinical Features Form, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Breast (EORTC QLQ- BR23) measures specific to breast cancer were used to obtain data.
The average age of the patients was 45.65. The majority of patients were treated with the paclitaxel/paclitaxel+trastuzumab treatment protocol (60.42%), and more than half (54.16%) of these patients were on 5 or 6 treatments. The symptoms patients experienced the most commonly included being sensitive, weakness or energy loss and pain. The symptoms they experienced severely were included fatigue and energy loss and being sensitive. The most distressing symptoms were pain, worry, numbness in hands and feet. The overall well-being score of the patients as per the quality of life findings was 46.18±11.66. While the lowest score for the functional scales was in the social function subscale (66.32±15.18), the highest score for the symptom scales was in the pain subscale (42.01±15.37). The lowest score for the EORTC QLQ-BR23 scales was in the sexual life subscale (20.83±20.19); the highest score was in the body appearance subscale (65.8±23.96).
The results of the study are thought to be helpful for the oncology nurses in evaluating the patients in all aspects and in determining priorities for care. |
---|---|
AbstractList | Objective: The aim of this study is to evaluate the symptoms experience and quality of life in patients with breast cancer receiving the taxane class of drugs.Materials and Methods: This study was performed between November 2015 March 2016 in a chemotherapy unit of a university hospital with 48 patients, who agreed to participate in the study. The Memorial Symptom Rating Score (MSAS), Socio-demographic and Clinical Features Form, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Breast (EORTC QLQ- BR23) measures specific to breast cancer were used to obtain data.Results: The average age of the patients was 45.65. The majority of patients were treated with the paclitaxel/paclitaxel+trastuzumab treatment protocol (60.42%), and more than half (54.16%) of these patients were on 5 or 6 treatments. The symptoms patients experienced the most commonly included being sensitive, weakness or energy loss and pain. The symptoms they experienced severely were included fatigue and energy loss and being sensitive. The most distressing symptoms were pain, worry, numbness in hands and feet. The overall well-being score of the patients as per the quality of life findings was 46.18±11.66. While the lowest score for the functional scales was in the social function subscale (66.32±15.18), the highest score for the symptom scales was in the pain subscale (42.01±15.37). The lowest score for the EORTC QLQ-BR23 scales was in the sexual life subscale (20.83±20.19); the highest score was in the body appearance subscale (65.8±23.96).Conclusion: The results of the study are thought to be helpful for the oncology nurses in evaluating the patients in all aspects and in determining priorities for care. The aim of this study is to evaluate the symptoms experience and quality of life in patients with breast cancer receiving the taxane class of drugs. This study was performed between November 2015 March 2016 in a chemotherapy unit of a university hospital with 48 patients, who agreed to participate in the study. The Memorial Symptom Rating Score (MSAS), Socio-demographic and Clinical Features Form, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Breast (EORTC QLQ- BR23) measures specific to breast cancer were used to obtain data. The average age of the patients was 45.65. The majority of patients were treated with the paclitaxel/paclitaxel+trastuzumab treatment protocol (60.42%), and more than half (54.16%) of these patients were on 5 or 6 treatments. The symptoms patients experienced the most commonly included being sensitive, weakness or energy loss and pain. The symptoms they experienced severely were included fatigue and energy loss and being sensitive. The most distressing symptoms were pain, worry, numbness in hands and feet. The overall well-being score of the patients as per the quality of life findings was 46.18±11.66. While the lowest score for the functional scales was in the social function subscale (66.32±15.18), the highest score for the symptom scales was in the pain subscale (42.01±15.37). The lowest score for the EORTC QLQ-BR23 scales was in the sexual life subscale (20.83±20.19); the highest score was in the body appearance subscale (65.8±23.96). The results of the study are thought to be helpful for the oncology nurses in evaluating the patients in all aspects and in determining priorities for care. OBJECTIVEThe aim of this study is to evaluate the symptoms experience and quality of life in patients with breast cancer receiving the taxane class of drugs. MATERIALS AND METHODSThis study was performed between November 2015 March 2016 in a chemotherapy unit of a university hospital with 48 patients, who agreed to participate in the study. The Memorial Symptom Rating Score (MSAS), Socio-demographic and Clinical Features Form, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Breast (EORTC QLQ- BR23) measures specific to breast cancer were used to obtain data. RESULTSThe average age of the patients was 45.65. The majority of patients were treated with the paclitaxel/paclitaxel+trastuzumab treatment protocol (60.42%), and more than half (54.16%) of these patients were on 5 or 6 treatments. The symptoms patients experienced the most commonly included being sensitive, weakness or energy loss and pain. The symptoms they experienced severely were included fatigue and energy loss and being sensitive. The most distressing symptoms were pain, worry, numbness in hands and feet. The overall well-being score of the patients as per the quality of life findings was 46.18±11.66. While the lowest score for the functional scales was in the social function subscale (66.32±15.18), the highest score for the symptom scales was in the pain subscale (42.01±15.37). The lowest score for the EORTC QLQ-BR23 scales was in the sexual life subscale (20.83±20.19); the highest score was in the body appearance subscale (65.8±23.96). CONCLUSIONThe results of the study are thought to be helpful for the oncology nurses in evaluating the patients in all aspects and in determining priorities for care. |
Author | Kırca, Kamile Kutlutürkan, Sevinç |
AuthorAffiliation | 1 Department of Nursing, Kırıkkale University School of Health Sciences, Kırıkkale, Turkey 2 Department of Nursing, Gazi University School of Health Sciences, Ankara, Turkey |
AuthorAffiliation_xml | – name: 1 Department of Nursing, Kırıkkale University School of Health Sciences, Kırıkkale, Turkey – name: 2 Department of Nursing, Gazi University School of Health Sciences, Ankara, Turkey |
Author_xml | – sequence: 1 givenname: Kamile surname: Kirca fullname: Kirca, Kamile – sequence: 2 givenname: Sevinc surname: Kutluturkan fullname: Kutluturkan, Sevinc |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30123880$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkctvEzEQhy1UREvplSPykUuCX-tdX5AglFIpEq8gjtbYO5s42kewN1Xz39fblKo92bK_-Tye32ty0g89EvKWs3nBC_EBt24zF4xXc1lWxQtyJoqqnLFK8pMn-1NykdKWscyVZSWrV-RUMi5kVbEz0v8-dLtx6BK9vN1hDNh7pNDX9Oce2jAe6NDQZWiQhp6uNkh_wJiZMdG_YdzQzxEhjXQBuSrSX-gx3IR-fU-u4BZ6pIsWUposX-J-nd6Qlw20CS8e1nPy5-vlavFttvx-db34tJx5VchxJhpX1NpAbrnxIKuCu1orgUxxpgVirYwztZZaS6bAeTDaMdVg7WStBTTynFwfvfUAW7uLoYN4sAMEe38wxLWFOAbfovVcKjACjJGFKrh3Sso8O1EK48pG6Oz6eHTt9q7D2ufvR2ifSZ_f9GFj18ON1cwIrkwWvH8QxOHfHtNou5A8tm2ez7BPVjDDhNGcTej8iPo4pBSxeXyGMztlbqfM7ZS5nTLPBe-eNveI_09Y3gF17amc |
CitedBy_id | crossref_primary_10_5114_hpr_2020_93757 crossref_primary_10_1021_acsomega_2c07250 crossref_primary_10_1007_s11764_023_01450_w crossref_primary_10_3390_ijms23042144 crossref_primary_10_3389_fphar_2023_1106030 |
ContentType | Journal Article |
Copyright | Copyright © 2018 Turkish Federation of Breast Diseases Associations 2018 |
Copyright_xml | – notice: Copyright © 2018 Turkish Federation of Breast Diseases Associations 2018 |
CorporateAuthor | Department of Nursing, Kirikkale University School of Health Sciences, Kirikkale, Turkey Department of Nursing, Gazi University School of Health Sciences, Ankara, Turkey |
CorporateAuthor_xml | – name: Department of Nursing, Gazi University School of Health Sciences, Ankara, Turkey – name: Department of Nursing, Kirikkale University School of Health Sciences, Kirikkale, Turkey |
DBID | NPM AAYXX CITATION 7X8 5PM DOA |
DOI | 10.5152/ejbh.2018.3785 |
DatabaseName | PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2587-0831 |
EndPage | 155 |
ExternalDocumentID | oai_doaj_org_article_c134a92a9935451cb4332582729b7f26 10_5152_ejbh_2018_3785 30123880 |
Genre | Journal Article |
GroupedDBID | ABDBF ALMA_UNASSIGNED_HOLDINGS EBD EMOBN EOJEC ESX GROUPED_DOAJ HYE IAO ICW IHR ITC M~E NPM OBODZ OK1 RPM TUS ~8M AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c453t-2fb5d69a018fca3851bd642e041062eed49b9d6366304abca96b04fedb3d62af3 |
IEDL.DBID | RPM |
ISSN | 2587-0831 |
IngestDate | Sun Sep 29 07:27:25 EDT 2024 Tue Sep 17 21:26:47 EDT 2024 Fri Jun 28 15:26:46 EDT 2024 Thu Sep 26 19:55:09 EDT 2024 Sat Sep 28 08:23:12 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | symptom Breast cancer quality of life taxane |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c453t-2fb5d69a018fca3851bd642e041062eed49b9d6366304abca96b04fedb3d62af3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-3230-0775 0000-0001-7019-6107 |
OpenAccessLink | https://doaj.org/article/c134a92a9935451cb4332582729b7f26 |
PMID | 30123880 |
PQID | 2090296109 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_c134a92a9935451cb4332582729b7f26 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6092149 proquest_miscellaneous_2090296109 crossref_primary_10_5152_ejbh_2018_3785 pubmed_primary_30123880 |
PublicationCentury | 2000 |
PublicationDate | 2018-07-01 |
PublicationDateYYYYMMDD | 2018-07-01 |
PublicationDate_xml | – month: 07 year: 2018 text: 2018-07-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Turkey |
PublicationPlace_xml | – name: Turkey |
PublicationTitle | European journal of breast health |
PublicationTitleAlternate | Eur J Breast Health |
PublicationYear | 2018 |
Publisher | Turkish Federation of Breast Diseases Associations Galenos Publishing House |
Publisher_xml | – name: Turkish Federation of Breast Diseases Associations – name: Galenos Publishing House |
SSID | ssj0001877838 |
Score | 2.1665008 |
Snippet | The aim of this study is to evaluate the symptoms experience and quality of life in patients with breast cancer receiving the taxane class of drugs.
This study... OBJECTIVEThe aim of this study is to evaluate the symptoms experience and quality of life in patients with breast cancer receiving the taxane class of drugs.... Objective: The aim of this study is to evaluate the symptoms experience and quality of life in patients with breast cancer receiving the taxane class of... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 148 |
SubjectTerms | breast cancer Original quality of life symptom taxane |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA7iyYsovuqLCIKnapukaXP0iYiKoKK3kjSJVtiu7HZB_70zzaq7Injx2pYm_b40M5MZviFkl3ELW14u49xkHtOMIlaeZzEmHyueWCc1nndcXcvze3HxmD1OtPrCmrAgDxyAO6hSLrRiGuwoGPu0Mii4lRUMnEKTexbEttNsIpjqTleKPC94EVQawWSzA_diMPeQFvs8x8bJE1aoE-v_zcP8WSg5YXnOFsj82GWkh2Gqi2TGNUukuX3vvbb93pB-ixVT3VgaRDHead_Ty9o7WjcUlgK9CfqpQ_pQt8_0CEvRW3qMlA8ouI6uxoOF7sk7_aYbR7tumfiWk8HoabhM7s9O747P43HvhLgSGW9j5k1mpdLwwb7SHPwqYyHUcImAGJCBYRTKKCs5OByJ0KbSSppEeGcNt5Jpz1fIbNNv3BqhMgHWWJUmjnuRVV6hYIviXhrhc-uLiOx9Ylm-BomMEkILRL1E1EtEvUTUI3KEUH89hdLW3QUgvBwTXv5FeER2Pokq4VfA_Aag0h8NYRyVMIX68RFZDcR9DcXRd4S9KiL5FKVTc5m-09TPndy2TBSDOHL9Pya_QeYQjVDvu0lm28HIbYFX05rtbgF_AOoA84M priority: 102 providerName: Directory of Open Access Journals |
Title | Symptoms Experience and Quality of Life in The Patients With Breast Cancer Receiving The Taxane Class of Drugs |
URI | https://www.ncbi.nlm.nih.gov/pubmed/30123880 https://search.proquest.com/docview/2090296109 https://pubmed.ncbi.nlm.nih.gov/PMC6092149 https://doaj.org/article/c134a92a9935451cb4332582729b7f26 |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3PT9swFLaAXXaZNu1XNlYZadJOaVPbceIjLasQgglpoHGLbMeGoDWp2lSC_37vOQ1rJ067Jk7svM-Jv_cjnwn5yngJn7xMxplJPaYZRaw8T2NMPlqelE5qjHdc_JCn1-LsJr3ZI2n_L0wo2remGta_58O6ugu1lYu5HfV1YqPLi6lMFANmP9on-xnnWy56CKzkWZbzvBNohNWajdy9wbTDOB_yLMetajgSiRyVILfWoiDZ_xzP_Ldccmv9mb0mrzbEkR53A3xD9lz9ltQ_H-eLtpmv6F_JYqrrknbSGI-08fS88o5WNYUJQS87FdUV_VW1d3SCBektnSLwSwoE0lUYXggtr_SDrh0Ne2biXU6W69vVO3I9-341PY03OyjEVqS8jZk3aSmVhmf3VnNgV6YEh8MlAjxBBsujUEaVkgPtSIQ2VitpEuFdaXgpmfb8PTmom9p9JFQmgB2z48RxL1LrFcq2KO6lET4rfR6Rb70ti0UnlFGAg4EAFAhAgQAUCEBEJmjqp1YocB0ONMvbYgNzYcdcaMU00CfgeGNrUGctzRn4AibzTEbkqAeqgBcCsxxglWa9gn5UwhSqyEfkQwfcU1c98BHJdiDdGcvuGZiDQXR7M-c-_feVn8lLNEFX6ntIDtrl2n0BQtOaAXlxPDmZzAYhIDAI0_kPgq_4Gg |
link.rule.ids | 230,315,733,786,790,870,891,2115,27957,27958,53827,53829 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbGeIAXLuKycDUSEk9JU9tx4kdWmAq00yQ62FtkO_YWoEnVphLj13NO0ox24gVeYyd2fD7nfPY5-UzIa8YL-OSlMkxN4jHMKELleRJi8NHyuHBS437H9FiOT8XHs-RsjyT9vzBt0r41ZVT9mEdVedHmVi7mdtDniQ1OpiMZKwbMfnCD3IT5ytKtRXq7tZKlacazTqIR_DUbuG8GAw_DLOJphofVcKQSGWpBbnmjVrT_b0zzesLklgc6uku-9H3vEk--R-vGRPbXNVnHf365e-TOhpPSt13xfbLnqgek-nw5XzT1fEX_qCFTXRW0U924pLWnk9I7WlYUsEZPOoHWFf1aNhf0EHPdGzpCTC0pcFNX4s5FW3Omf-rK0fY4TnzKu-X6fPWQnB69n43G4eZwhtCKhDch8yYppNIwqN5qDsTNFLCWcbGARSYDzyuUUYXkwGhioY3VSppYeFcYXkimPX9E9qu6cgeEyhhgwewwdtyLxHqFijCKe2mETwufBeRNb6R80Wlw5LB2QcvmaNkcLZujZQNyiDa8qoXa2e2FenmebwY5t0MutGIamBnQx6E1KOGWAIyYMqlnMiCvegTkMNcwgAKjUq9X0I6KmUKB-oA87hBx1VSPqICkO1jZ6ctuCSCg1fPeWPzJf9_5ktwaz6aTfPLh-NNTchuHo8sofkb2m-XaPQfe1JgX7Sz5DR49F7k |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagSIgLD_FoeBoJiVMeaydOfKRbVgXaaiVaUXGJ_GwDbLLazUqUX89Msim7FadeEyd2ZsaZbzyjbwh5x7iFX14uwlxnHtOMaSg9z0JMPhqeWCcUnnccHYuD0_TzWXa20eqrK9o3uorqX7Oori662sr5zMRDnVg8PRqLRDJA9vHc-vg2uQN7lsmNQL07XinyvOBFT9MIPpvF7ofG5MOoiHheYMMajnCiQD7IDY_UEff_D21eL5rc8EKTB-T7sP6--ORntGp1ZP5co3a80Qc-JPfX2JR-6Ic8Irdc_ZjUXy9n87aZLek_VmSqakt79o1L2nh6WHlHq5qCzdFpT9S6pN-q9oLuYc17S8doWwsKGNVVeILRjTxRv1XtaNeWE9-yv1idL5-Q08nHk_FBuG7SEJo0423IvM6skAoE643iAOC0hZjGJSkEmww8cCq1tIIDsklSpY2SQiepd1ZzK5jy_CnZqZva7RIqEjAPZkaJ4z7NjJfIDCO5Fzr1ufVFQN4PiirnPRdHCTEMardE7Zao3RK1G5A91OPVKOTQ7i40i_NyLejSjHiqJFOA0ABGjoxGKresYBBu6NwzEZC3gxWUsOcwkQJSaVZLmEcmTCJRfUCe9VZxNdVgVQHJt-xlay3bd8AKOl7vtdaf3_jJN-TudH9SHn46_vKC3ENp9IXFL8lOu1i5VwCfWv262yh_Ad3dGjk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Symptoms+Experience+and+Quality+of+Life+in+The+Patients+With+Breast+Cancer+Receiving+The+Taxane+Class+of+Drugs&rft.jtitle=European+journal+of+breast+health&rft.au=Kirca%2C+Kamile&rft.au=Kutluturkan%2C+Sevinc&rft.date=2018-07-01&rft.issn=2587-0831&rft.eissn=2587-0831&rft_id=info:doi/10.5152%2Fejbh.2018.3785&rft.externalDBID=n%2Fa&rft.externalDocID=10_5152_ejbh_2018_3785 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2587-0831&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2587-0831&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2587-0831&client=summon |